BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21440745)

  • 1. Hematologic side effects of azathioprine and mycophenolate in kidney transplantation.
    Habas E; Khammaj A; Rayani A
    Transplant Proc; 2011 Mar; 43(2):504-6. PubMed ID: 21440745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients.
    Khosroshahi HT; Asghari A; Estakhr R; Baiaz B; Ardalan MR; Shoja MM
    Transplant Proc; 2006 Sep; 38(7):2077-9. PubMed ID: 16980004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
    Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
    J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
    Bernabeu-Wittel M; Naranjo M; Cisneros JM; Cañas E; Gentil MA; Algarra G; Pereira P; González-Roncero FJ; de Alarcón A; Pachón J
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):173-80. PubMed ID: 11957018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose sirolimus in combination with mycophenolate mofetil improves kidney graft function late after renal transplantation and suggests pharmacokinetic interaction of both immunosuppressive drugs.
    Renders L; Steinbach R; Valerius T; Schöcklmann HO; Kunzendorf U
    Kidney Blood Press Res; 2004; 27(3):181-5. PubMed ID: 15256815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
    Basic-Jukic N; Kes P; Bubic-Filipi LJ; Puretic Z; Brunetta B; Pasini J
    Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
    Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM
    Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
    Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
    J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
    Rivinius R; Helmschrott M; Ruhparwar A; Schmack B; Klein B; Erbel C; Gleissner CA; Akhavanpoor M; Frankenstein L; Darche FF; Thomas D; Ehlermann P; Bruckner T; Katus HA; Doesch AO
    Drug Des Devel Ther; 2015; 9():93-102. PubMed ID: 25552900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transplanted kidney function in patients on two different doses of mycophenolate mofetil.
    Khosroshahi HT; Nahali A; Gojazadeh M; Shoja MM
    Transplant Proc; 2006 Sep; 38(7):2035-7. PubMed ID: 16979991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil dose reduction in renal transplant recipients: a 5-year follow-up study.
    Khosroshahi HT; Shoja MM; Peyrovifar A; Hashemi SR; Amjadi M
    Transplant Proc; 2009 Sep; 41(7):2797-9. PubMed ID: 19765438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?
    Prokopenko E; Scherbakova E; Vatazin A; Pasov S; Budnikova N; Agafonova S
    Drugs Exp Clin Res; 2005; 31(5-6):199-205. PubMed ID: 16425976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
    Dooley MA; Jayne D; Ginzler EM; Isenberg D; Olsen NJ; Wofsy D; Eitner F; Appel GB; Contreras G; Lisk L; Solomons N;
    N Engl J Med; 2011 Nov; 365(20):1886-95. PubMed ID: 22087680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience).
    Hakemi M; Shahebrahimi K; Ganji MR; Najafi I; Broumand B
    Transplant Proc; 2002 Sep; 34(6):2091-2. PubMed ID: 12270326
    [No Abstract]   [Full Text] [Related]  

  • 17. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA; Gheith OA; Ismael AM; Baz ME; Shehab El-Dein AB; Ghoneim MA
    Exp Clin Transplant; 2008 Mar; 6(1):48-53. PubMed ID: 18405245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from azathioprine to mycophenolate mofetil followed by calcineurin inhibitor minimization or elimination in patients with chronic allograft dysfunction.
    Garcia R; Pinheiro-Machado PG; Felipe CR; Park SI; Silva LA; Franco MF; Tedesco-Silva H; Medina-Pestana JO
    Transplant Proc; 2006 Nov; 38(9):2872-8. PubMed ID: 17112853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of azathioprine versus mycophenolate mofetil in cyclosporine-based immunosuppression in kidney transplantation: 10 years of experience at a single center.
    Kwon O; Cho JH; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2013 May; 45(4):1487-90. PubMed ID: 23726603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.